Circular RNA MT-RNR2 in Mitochondrial Function and Aging

Key Takeaways

• circMT‑RNR2 levels drop in aged tissues
• GRSF1 binds circular MT‑RNR2, influencing TCA enzymes
• Depletion of circMT‑RNR2 accelerates senescence
• Circular MT‑RNR2 may regulate glucose metabolism
• Targeting circMT‑RNR2 could improve mitochondrial health

Summary

Researchers identified mitochondrial circular RNA MT‑RNR2 as abundant in young cells but depleted in older individuals and senescent fibroblasts. The RNA‑binding protein GRSF1 binds both linear and circular MT‑RNR2, linking it to TCA‑cycle enzymes and glucose metabolism. Loss of GRSF1 reduces circMT‑RNR2 and fumarate/succinate levels, accelerating cellular senescence and mitochondrial dysfunction. The study suggests restoring circMT‑RNR2 could preserve mitochondrial function and slow age‑related decline.

Pulse Analysis

Circular RNAs have emerged as a hidden layer of gene regulation, yet their roles inside mitochondria remain largely unexplored. Recent profiling of human cohorts revealed that the mitochondrial genome produces a prominent circular transcript, MT‑RNR2, which is highly expressed in youthful tissues but markedly reduced in older individuals and senescent fibroblasts. This age‑dependent shift points to a novel non‑coding RNA that may act as a molecular switch governing mitochondrial resilience, a key factor in cellular longevity.

The study highlights the RNA‑binding protein GRSF1 as a critical partner for both linear and circular MT‑RNR2. GRSF1’s interaction facilitates the recruitment of circMT‑RNR2 to several TCA‑cycle enzymes, influencing the production of fumarate and succinate. When GRSF1 is knocked down, circMT‑RNR2 levels fall, metabolic intermediates dwindle, and cells exhibit accelerated senescence and impaired oxidative phosphorylation. These mechanistic insights connect a specific circular RNA to core metabolic pathways, suggesting that circMT‑RNR2 helps sustain glucose oxidation and energy output in proliferating cells.

From a translational perspective, restoring circMT‑RNR2 or modulating its binding partners could become a strategy to rejuvenate mitochondrial function in aging tissues. Future work will need to decipher the biogenesis of mitochondrial circular RNAs, likely involving trans‑splicing, and test whether therapeutic delivery of circMT‑RNR2 can reverse metabolic decline in animal models. If successful, such interventions may address age‑related disorders ranging from neurodegeneration to metabolic syndrome, positioning circular RNA therapeutics at the frontier of precision geroscience.